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poly-ADP-ribose formation
after oxidative stress
Ingrid Kassner1,2, Anneli Andersson1,2, Monika Fey1,
Martin Tomas3,4, Elisa Ferrando-May3 and Michael O. Hottiger1
1Institute of Veterinary Biochemistry and Molecular Biology, and 2Life Science Zurich
Graduate School, Molecular Life Science Program, University of Zurich,
Winterthurerstrasse 190, 8057 Zurich, Switzerland
3Department of Biology, Bioimaging Center, and 4Department of Physics, Center for
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ADP-ribosyltransferase diphtheria toxin-like 1 (ARTD1, formerly PARP1) is
localized in the nucleus, where it ADP-ribosylates specific target proteins.
The post-translational modification (PTM) with a single ADP-ribose unit or
with polymeric ADP-ribose (PAR) chains regulates protein function as well
as protein–protein interactions and is implicated in many biological proces-
ses and diseases. SET7/9 (Setd7, KMT7) is a protein methyltransferase that
catalyses lysine monomethylation of histones, but also methylates many non-
histone target proteins such as p53 or DNMT1. Here, we identify ARTD1 as
a new SET7/9 target protein that is methylated at K508 in vitro and in vivo.
ARTD1 auto-modification inhibits its methylation by SET7/9, while auto-
poly-ADP-ribosylation is not impaired by prior methylation of ARTD1.
Moreover, ARTD1 methylation by SET7/9 enhances the synthesis of PAR upon
oxidative stress in vivo. Furthermore, laser irradiation-induced PAR formation
and ARTD1 recruitment to sites of DNA damage in a SET7/9-dependent
manner. Together, these results reveal a novel mechanism for the regulation
of cellular ARTD1 activity by SET7/9 to assure efficient PAR formation upon
cellular stress.2. Background
ADP-ribosyltransferase diphtheria toxin-like 1 (ARTD1, formerly named
PARP1, [1]) is a nuclear protein that post-translationally modifies proteins by
transferring the ADP-ribose moiety from NADþ to specific amino acid residues
of target proteins. It is the best described member of the ADP-ribosyltransferase
(ART) protein family, which currently comprises 22 human enzymes [1].
ARTD1 is not only the main nuclear ART, but also the primary acceptor for
polymeric ADP-ribose (PAR). ARTD1 can be ADP-ribosylated at specific
lysine residues and is also modified by acetylation and sumoylation bet-
ween the amino acid residues 481 and 525 [2–4]. Protein modification with a
single ADP-ribose unit or with PAR chains regulates protein function and is
implicated in biological processes such as transcriptional control, cell differen-
tiation or cell-cycle regulation [5,6]. Many cellular functions of ARTD1 are
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or the ADP-ribosylation of target proteins in the cell nucleus
[5,7]. For example, histones or transcription factors are poly-
ADP-ribosylated (PARylated) by ARTD1, which causes
concomitant changes in chromatin structure and DNA
metabolism [8,9].
Genotoxic and cellular stresses activate ARTD1 enzyme
activity [10]. However, the detailed upstream mechanisms
leading to the activation of ARTD1 and the involvement
of PTMs-modulating ARTD1 activity are little understood.
In vitro, the DNA-dependent interaction between the
amino-terminal DNA-binding domain and the catalytic
domain of ARTD1 increased Vmax and decreased the Km
for NADþ [4]. The amount of DNA in this study was kept
at a saturating 1 : 1 ratio (DNA : ARTD1 dimer). It is currently
not clear whether ARTD1 activity and the subsequent PAR
formation under non-saturating DNA levels depend on
additional regulatory mechanisms.
SET7/9 (also called Setd7 or KMT7) was discovered as a
histone methyltransferase that causes monomethylation of
histone 3 lysine 4 (H3K4me1) [11] and is thereby involved
in the regulation of euchromatic gene expression [12–14].
However, SET7/9 has only weak activity on nucleosomes
[15], which implies that the main targets of the enzyme are
non-histone proteins. In agreement with this hypothesis,
numerous non-histone proteins such as Dnmt1 (reduction
in stability), p53 (activation and stabilization), TAF10
(increased affinity for polymerase II), oestrogen receptor a
(activation and stabilization), pRb, p65, MyoD and Tat
protein of HIV1 are methylated by SET7/9 [16–24]. In
addition, a recent study identified up to 90 new non-histone
SET7/9 target peptides and a strong methylation of free H2A
and H2B tails [25]. This promiscuous targeting of different
substrates by SET7/9 suggests a low specificity of the
enzyme. SET7/9 knockout mice are viable and fertile and
loss of SET7/9 does not seem to impair p53-dependent cell-
cycle arrest or apoptosis following DNA damage [26,27],
although SET7/9 was originally thought to regulate p53
activity in human cells [16]. SET7/9 preferentially modifies
positively charged amino acid regions and methylates the
last lysine residue in the motif [K.R] [S.KYARTPN] [K]
[25]. Peptides that do not perfectly match this sequence can
be methylated to a lesser extent. In cells, a strong interaction
of acceptor proteins with the SET7/9 methyltransferase
might stimulate the transfer of a methyl group to weak
target sites. Hence, a weaker methylation does not have to
imply a lower biological importance [25].
SET7/9-mediatedmonomethylation of non-histone proteins
is a reversible PTM that can be removed by demethyl-
ases such as the lysine-specific demethylase 1 (LSD1) [28,29]
and likely also by the close homologue LSD2. Both proteins
are flavin-dependent demethylases that are specific for
mono- and dimethylated lysines and which are part of
histone modification complexes that control cell-specific gene
expression [30,31].
The study presented here identifies ARTD1 as a new
SET7/9 target protein that is methylated at K508, which
enhances PAR synthesis upon oxidative stress. Similarly,
SET7/9 also affected PAR synthesis and ARTD1 recruitment
to sites of DNA damage in vivo upon laser irradiation. These
results define methylation of ARTD1 by SET7/9 as an
additional regulatory element for cellular ADP-ribosylation
and ARTD1 enzymatic activity.3. Results and discussion
3.1. ARTD1 is methylated in vitro and in vivo at K508
by SET7/9
Based on methylation profile searches and preliminary
experiments, it was hypothesized that SET7/9 directly methyl-
ates ARTD1. To determine whether SET7/9 indeed modifies
ARTD1, biochemical in vitro methylation assays with purified
proteins were performed. SET7/9 methylated the known
substrate histoneH3 aswell as full-lengthARTD1,while neither
GST nor ARTD2, another member of the ARTD family,
was modified (figure 1a). To localize the modification site, pur-
ifiedARTD1 fragments covering thewholeaminoacid sequence
were methylated by SET7/9 in vitro (figure 1b). The potential
SET7/9 modification site(s) in ARTD1 could be narrowed
down to the auto-modification domain (AD) consisting of
amino acids 373–524, which was strongly methylated in vitro,
while all other tested ARTD1 fragments (containing the DNA-
binding (DBD), WGR or catalytic (CAT) domains) were not
methylated (figure 1b). In silico analysis identified lysine 508
(K508) as the putative target site as itwas the only lysine residue
within this region matching the published [KR] [STA] [K(me)]
consensus motif for SET7/9-dependent methylation [18].
Mutation of K508 to arginine (K508R) indeed abolished SET7/9-
dependent methylation of full-length ARTD1 (figure 1c).
ARTD1 K508 was confirmed as the target residue of SET7/9 by
mass spectrometric analysis of recombinant ARTD1 (373–524)
in vitro methylated by SET7/9 (see electronic supplementary
material, figure S1a,b). To confirm methylation of ARTD1 K508
in cells, a polyclonal antibody against a synthetic human
ARTD1 peptide containing monomethylated K508 was genera-
ted. The anti-meARTD1 antibody specifically recognized the
monomethylated peptide (see electronic supplementary mate-
rial, figure S1c) and full-length ARTD1 that was methylated
by SET7/9 in vitro (see electronic supplementary material,
figure S1d), while the methylation-deficient K508R mutant was
not detected (figure 1d). In vivo, the same antibody specifically
detected the methylation of ARTD1 in cells overexpressing
SET7/9 (figure 1e,f ). The antibody did not detect methylation
of overexpressed mouse ARTD1 in mouse cells, which was
most probably owing to sequence differences between human
and mouse ARTD1 at the methylation site.
These results defined ARTD1 as a new target for SET7/9-
dependent methylation in vitro and in vivo and identi-
fied K508 as the main target site for SET7/9-dependent
methylation of ARTD1.
3.2. ARTD1 auto-modification inhibits its methylation
by SET7/9
Interestingly, the SET7/9 target residue K508 lies within a heav-
ily modified region (aa 486–524) of the ARTD1 AD domain that
comprises five acetylation and three ADP-ribosylation sites as
well as one lysine residue that can be sumoylated (see electronic
supplementary material, figure S2). Modification of ARTD1
with SUMO did not affect its ADP-ribosylation activity, but
completely abrogated p300-mediated acetylation of ARTD1,
revealing an intriguing crosstalk of sumoylation and acetylation
on ARTD1 [2]. Crosstalk between different PTMs of the same
modified amino acid residue has been documented in particular
for modifications comprising the histone code [32–34]. It was
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Figure 1. ARTD1 is methylated at K508 by SET7/9 in vitro and in vivo. (a) GST, ARTD1, ARTD2 and H3 were incubated with SET7/9 and 14C-labelled SAM in an in
vitro methylation assay, separated by SDS-PAGE and analysed by autoradiography (14C). Coomassie blue (CB) stained gels are shown below. (b) Full-length
ARTD1 and fragments covering the whole protein were incubated in an in vitro methylation assay and analysed by autoradiography. (c) Decreasing amounts
of WT ARTD1 and K508R ARTD1 were methylated by SET7/9 and analysed by autoradiography. (d ) An antibody directed against a peptide carrying the methylated
lysine residue of ARTD1 was generated and tested in a western blot with in vitro methylated ARTD1 WT and K508R. (e) U2OS cells were transfected with scrambled
siRNA (scr) or siRNA directed against ARTD1. One day later, cells were transfected with an empty vector or with a plasmid containing WT SET7/9. Whole cell extracts
were analysed by western blot on day 3 after knockdown using the same antibody as in (d ). ( f ) U2OS cells were co-transfected with HA-ARTD1 (WT or K508R) and
EGFP or Flag-HA-SET7/9 (WT or H297A). After immunoprecipitation with an anti-HA antibody, whole cell extracts and IP samples were analysed by western blotting
with the indicated antibodies. All experiments were repeated at least twice, gave a similar result, and one representative blot is shown.
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lation and SET7/9-dependent methylation of ARTD1 in vitro.
Prior stimulation of recombinant ARTD1with DNA in the pres-
ence of NADþ and subsequent auto-modification completely
inhibited methylation by SET7/9 (figure 2a). Inhibition of
ADP-ribosylation by 3-aminobenzamide from the beginning
(3-AB; þ) reverted this effect on ARTD1 methylation, while
3-AB addition after auto-modification, but before addition of
SET7/9 (3-AB;+), still resulted in markedly decreased methyl-
ation (figure 2a). Consequently, these experiments suggested
that auto-ADP-ribosylation of ARTD1, but not a possible ADP-
ribosylation of SET7/9 by ARTD1, prevented subsequent
methylation. The sharp band of methylated ARTD1 running at
the height of unmodified ARTD1 strengthened the conclusion
that SET7/9 only methylated ARTD1 that was not or only
slightly ADP-ribosylated.
By contrast, auto-PARylation of ARTD1 was not impaired
by prior methylation of ARTD1 as indicated by the smear ofmethylated ARTD1 upon incubation with cold NADþ and
DNA (figure 2b). Similarly, methylation of the 373–524
ARTD1 fragment by SET7/9 did not affect subsequent acety-
lation by p300 (figure 2c(i)). The experiment was controlled
with the enzymatically inactive H297A SET7/9 mutant and
methylation of ARTD1 was confirmed in a parallel experiment
using 14C-SAM (figure 2c(ii)).
These results suggested that SET7/9-dependent methyl-
ation of ARTD1 is influenced by ARTD1 auto-modification,
while neither PARylation itself nor acetylation by p300 is
impaired by the methyl-modification of K508.3.3. SET7/9-dependent methylation stimulates
ARTD1 activity
In order to test the hypothesis that SET7/9 regulates the
enzymatic activity of ARTD1 in vivo, we first confirmed
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Figure 2. ARTD1 methylation by SET7/9 does not influence its PARylation or acetylation but is inhibited by ARTD1 auto-modification. (a) Recombinant ARTD1 was
methylated by SET7/9 after ADP-ribosylation in the presence or absence of DNA and 3-AB. +: 3-AB was added after the ADP-ribosylation reaction. (b) ARTD1 was
first incubated with SET7/9 in the presence or absence of 14C-SAM and afterwards incubated with activating DNA and cold NADþ to allow auto-modification.
(c) ARTD1 (373–524) was first incubated with WT SET7/9 or an enzymatic dead mutant (H297A) in the presence of cold SAM and afterwards acetylated with p300 and
14C-AcCoA (i). Methylation was controlled with 14C-SAM (ii). All experiments were repeated at least twice, gave a similar result, and one representative blot is shown.
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While ARTD1 was only present in the nucleus and enriched
in the nucleoli, SET7/9 was localized throughout the cell
except in the nucleoli (see electronic supplementary material,
figure S3a). Next, Flag-tagged wild-type (WT) SET7/9
was overexpressed and PAR formation following oxidative
stress byH2O2was determined (see figure 3a and electronic sup-
plementary material, figure S3b). PAR formation was indeed
increased upon overexpression of WT SET7/9 (lanes 2 and 5),
even in unstimulated cells (lane 2), while the enzymatically inac-
tive SET7/9 mutant H297A did not cause this effect (lanes 3
and 6). To prove that SET7/9 stimulated PAR formation, we
analysed mouse fibroblasts lacking SET7/9. Upon H2O2 stimu-
lation, SET7/9-knockout MEFs showed significantly reduced
PAR staining and lower PAR-synthesizing activity as compared
with the WT control cells (see figure 3b,c and electronic sup-
plementary material, figure S3c), suggesting that SET7/9
regulates PAR formation in vivo. This was also confirmed by
SET7/9knockdown inU2OS cells (see electronic supplementary
material, figure S4a,b). Following oxidative stress by H2O2,
siSET7/9-treated cells formed less PAR than cells transfected
with a control siRNA (see figure 3d and electronic supplemen-
tary material, figure S4c). To further analyse the influence of
SET7/9 on ARTD1 enzymatic activity in cells, nuclear extracts
(NEs) from siRNA-treated U2OS cells (control siRNA or
siRNA directed against SET7/9 or ARTD1) were prepared and
auto-ADP-ribosylation of ARTD1 was tested in vitro in the
presence or absence of exogenous DNA. Downregulation ofSET7/9 reduced the basal ARTD1 activity to levels only
slightly above those in siARTD1 cells (in the absence of
exogenous DNA, figure 3e; electronic supplementary material,
figure S4d). This effect was also seen, but to a lesser extent,
when ARTD1 activity was stimulated by an excess of exogen-
ous DNA, suggesting that SET7/9 methylation regulates
ARTD1, especially in the absence of a strong stimulus.
These results suggested that SET7/9-dependentmethylation
stimulates ARTD1-dependent PAR formation in U2OS cells.3.4. SET7/9-dependent methylation of ARTD1 at
K508 regulates ADP-ribosylation in vivo
To elucidate whether SET7/9-dependent methylation of
ARTD1 at K508 is directly responsible for the observed influence
of SET7/9 on ARTD1-dependent PAR formation in vivo,
ARTD12/2MLFs were stably genetically complemented with
WTARTD1 or with two methylation-deficient mutants (K508A
and K508R). The WT and the mutant proteins were comparably
expressed in the NEs, but not detectable in the cytoplasmic
extracts (CEs) or the vector control (pRRL) (figure 4a). NEs con-
tainingWTormutantARTD1were incubatedwith radioactively
labelledNADþ, butwithout exogenousDNA, andARTD1 auto-
ADP-ribosylation was assessed. The methylation-deficient
ARTD1mutants K508A andK508R exhibitedmarkedly reduced
activity in comparison with the WT control (see figure 4b and
electronic supplementary material, figure S5a). Upon addition
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Figure 3. SET7/9-dependent methylation increases ARTD1 activity in cells. (a) After overexpression of Flag-SET7/9 WT or H297A, U2OS cells were treated with or
without 1 mM H2O2 for 5 min and PAR formation was analysed by western blot. (b) H2O2-induced PAR formation was analysed by immunofluorescence in SET7/9 KO
and WT MEFs. The intensity of the anti-PAR-stained cells was quantified. (c) H2O2-induced PAR formation in SET7/9 KO and WT MEFs was analysed as in (a).
(d ) U2OS cells were transfected with scrambled siRNA (scr) or siRNA targeting SET7/9. Three days after knockdown, H2O2-induced PAR formation was analysed
as in (a). Short and long exposures (se and le, respectively) of the anti-PAR blot are shown. (e) ARTD1 activity was analysed in NEs from U2OS cells after knockdown
of SET7/9 and ARTD1 for 3 days by radioactive ADP-ribosylation assays. All experiments were repeated at least twice, gave a similar result, and one representative
blot is shown. Quantifications are shown in the electronic supplementary material, figures S3b and S4c,d.
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K508A and K508R still exhibited reduced enzymatic activity,
but the effect was less pronounced as compared with conditions
without exogenous DNA (see figure 4b and electronic sup-
plementary material, figure S5b), again pointing at a SET7/9
methylation effect on ARTD1 activation.
This indicated that the methylation-deficient ARTD1
mutants (K508A and K508R) are enzymatically less active
and provided further evidence that SET7/9-dependent
methylation of ARTD1 at K508 affects its activity.3.5. Mutation of K508 affects ARTD1 recruitment
to damaged chromatin
The results described above suggested that SET7/9-dependent
methylation of ARTD1 at K508 regulates its enzymatic activity
at basal conditions of low levels of DNA damage and inresponse to oxidative stress (figures 1c and 4b). We hypoth-
esized that SET7/9-dependent methylation may influence
ARTD1 activity by affecting its interaction with chromatin,
but SET7/9 downregulation had no effect on the extraction
of ARTD1 under different salt concentrations (see electronic
supplementary material, figure S5c), suggesting that the affi-
nity of ARTD1 to undamaged chromatin was not changed.
However, methylation by SET7/9 may prime ARTD1 for effi-
cient recruitment to sites of DNA damage. In order to study
whether ARTD1 methylation affects its recruitment to sites of
DNA damage in vivo, cells expressing EGFP-tagged WT and
methylation-deficient ARTD1 were analysed by localized fem-
tosecond laser irradiation [35]. Thismethod allows studying the
kinetics of the recruitment of proteins to sites of DNA damage.
The nature of the lesion can be influenced via the irradiation
wavelength: at 775 nm, bothDNA strand breaks andUVphoto-
products are generated, while at 1050 nm mainly DNA strand
breaks are produced [35]. Irradiation with a wavelength of
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Figure 4. Methylation-deficient ARTD1 is less active and less efficiently recruited to sites of local DNA damage induced by femtosecond laser irradiation. (a) ARTD1
knockout MLFs were stably complemented with WT ARTD1 or two methylation-deficient mutants. Cells were then fractionated and CEs and NEs were analysed by
western blot. (b) ARTD1 activity in NE from (a) was analysed by radioactive PAR assays in the absence or presence of 5 pmol-activating DNA. Experiments in A and B
were repeated twice with a similar outcome and one representative blot is shown. Quantifications are shown in the electronic supplementary material, figure S5a,b.
(c) Recruitment of WT and K508R ARTD1 to sites of local DNA damage induced by femtosecond laser irradiation at l ¼ 1050 nm. (d ) Recruitment of macroH2A1.1-
EGFP to sites of local DNA damage induced by femtosecond laser irradiation at l ¼ 1050 nm. (e) Recruitment of WT and K508R ARTD1 to sites of DNA damage by
femtosecond laser irradiation at l ¼ 775 nm.
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(figure 4c) and the release of WT and K508R ARTD1 from
the irradiated sites was comparable (data not shown), suggest-
ing that methylation did not affect recruitment to sites of
DNA damage. However, laser microirradiation of live cells
[36] caused significantly lower recruitment of GFP-labelled
macroH2A1.1 in siSET7/9 cells as compared with WT
(figure 4d), which is indicative of reduced PAR synthesis or
different ADP-ribose structures. In contrast to irradiation with
1050 nm, femtosecond pulses at l ¼ 775 nm caused lower
recruitment of the K508R ARTD1 mutant (figure 4e). It is thus
possible that SET7/9 differentially affects ARTD1 stimulation
depending on the stress level and type of induced DNA
damage. In summary, these findings show that SET7/9-depen-
dent methylation stimulates ARTD1 enzymatic activity in
response to both oxidative and DNA stress.4. Conclusion
The results presented here suggest that SET7/9 methylates
ARTD1 in vivo and in vitro at lysine K508. The residue K508
was identified as the target site for SET7/9-dependent
methylation by site-directed mutagenesis and mass spec-
trometry, as well as with a specific polyclonal antibody
raised against this methylated site. Methylation of ARTD1
by SET7/9 did not prevent its consecutive ADP-ribosylation,
but affected ARTD1 recruitment to sites of local DNA
damage in vivo. Prior auto-ADP-ribosylation of ARTD1
impaired its methylation by SET7/9. Knockdown of SET7/9
or the expression of methylation-deficient ARTD1 in cellslacking WT ARTD1 caused reduced PAR formation in vitro
and in vivo. Moreover, overexpression of SET7/9, but not of
its enzymatically inactive mutant enhanced PAR formation
in untreated (basal) and H2O2-treated cells. These findings
identify ARTD1 as a new SET7/9 methylation target and
reveal a previously unknown mechanism for the regulation
of ARTD1 activity in cells.
The stimulatory effect of ARTD1 methylation on PAR for-
mation was most apparent if no exogenous DNA was added
to the reactions that were performed with NEs of SET7/9
knockdown cells or of cells genetically complemented with
a methylation-deficient ARTD1 mutant (the NEs may contain
low amounts of endogenous DNA). The effect was much
weaker under conditions of saturating DNA concentrations
(DNA : ARTD1 dimer ratio greater than 1). Methylation by
SET7/9 may thus represent a priming step that precedes
and facilitates the activation of ARTD1 by DNA or comprises
a DNA damage independent ARTD1 co-regulatory mechan-
ism. We have already provided evidence that DNA double
strand breaks are recognized and bound by the DBD of
ARTD1, which subsequently leads to binding to the CAT
domain, induces structural changes within the catalytic
cleft, increases the affinity for NADþ and stabilizes reaction
intermediates [4]. The identified SET7/9-dependent methyl-
ation site at K508 of ARTD1 lies within the central AD [4].
It is at the first glance surprising that ARTD1 is methylated
in the AD and not in one of the zinc fingers of the DNA-bind-
ing domain or in the catalytic domain of ARTD1, but
nevertheless affected in its enzymatic activity. However, the
AD harbours the ADP-ribose acceptor sites indicating that
this domain has to enter the catalytic cleft of ARTD1 to be
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sensitize ARTD1 for auto-modification by stabilizing the AD
in the catalytic domain of ARTD1 under non-genotoxic con-
ditions or in the presence of minimal DNA damage (fewer
DNA lesions compared with ARTD1 molecules). Alterna-
tively, methylation might induce structural changes, which
affect the binding of the DBD to the CAT, and thus sensitize
the enzyme for a special type of DNA damage (see below).
Likewise, methylated ARTD1 could exhibit higher affinity
for its substrate NADþ, and therefore show increased cataly-
tic activity. Based on this hypothesis, methylation of ARTD1
at K508 by SET7/9 serves as a sensitization step that assures
basal ARTD1 stimulation to assure PAR formation upon oxi-
dative stress. The fact that we observed a similar effect of
SET7/9 on the irradiation-induced PAR formation does not
necessarily imply a similar regulatory mechanism. However,
in order to compare such regulatory mechanisms and
to study ARTD1 stimulation by SET7/9 mechanistically,
structural analyses would be required.
The AD represents a PTM hotspot that is also modified by
ADP-ribosylation, acetylation and sumoylation [2–4]. Inter-
estingly, prior auto-modification of recombinant ARTD1
inhibited subsequent methylation by SET7/9 most probably
through steric hindrance (figure 2a), which is in agreement
with earlier studies providing evidence that the adjacent
lysines 498, 521 and 524 are the acceptor sides for ADP-
ribose [4]. Similarly, a synthetic ARTD1 peptide acetylated
at K508 could not be methylated by SET7/9 (see electronic
supplementary material, figure S5d ). However, the SET7/9-
mediated methylation of ARTD1 did not inhibit its auto-
ADP-ribosylation, indicating that the methylation would not
interfere with the positioning of this domain into the catalytic
domain. The functional relevance of this crosstalk needs to
be further defined. It is intriguing to speculate that ARTD1
auto-modification would hamper K508 methylation to avoid
an additional enhancement of its activity through this modi-
fication. Moreover, this could explain the inefficiency of
SET7/9-dependent methylation to further activate already
stimulated ARTD1 and hints again at a sensitization function
of SET7/9 for ARTD1 under non-stimulatory conditions.
The presence of SET7/9 had no influence on the overall
affinity of ARTD1 for (undamaged) chromatin in vivo. By
contrast, different recruitment of WT and K508R ARTD1 to
sites of local damage in the nucleus was observed. Interest-
ingly, WT and K508R ARTD1 showed similar recruitment
to DNA lesions induced with a wavelength of 1050 nm,
while a clear reduction was observed for the mutant after
treatment with laser pulses at 775 nm (figure 4c,e). This
effect was likely owing to the UV photoproducts generated
at 775 nm or to other differences in the types of lesion
induced by 775 nm versus 1050 nm irradiation. The latter
wavelength mainly induces DNA strand breaks but achieves
a lower overall level of damage than 775 nm at the irradiation
conditions used here [35]. Alternatively, a higher affinity for a
certain type of lesion or chromatin alteration (qualitative
difference) of the methylated ARTD1 protein, as compared
with the unmethylated or the non-methylatable mutant,
could also contribute to this behaviour.
The methylation of ARTD1 in vivo is very difficult to
detect. This indicates either low endogenous levels of
ARTD1 K508 methylation or further di- and trimethylation
at this residue by other methyl transferases. Here, SET7/9
strongly affected ARTD1 activity in the presence of lowamounts of DNA and upon stimulation by H2O2, although
we do not know whether this was due to oxidative damage
of the DNA. ARTD1 and its enzymatic activity are also impor-
tant for chromatin compaction [7,37]. An increased ARTD1
activity might lead to a more open chromatin, allowing
subsequent histone modifications (epigenetic events) chang-
ing the chromatin status and structure. Furthermore, our
studies provide evidence for the involvement of SET7/9 in
the oxidative stress response of the cell. Whether SET7/9 is
similarly required for the response to other signals (e.g.
N-methyl-N0-nitro-N-nitrosoguanidine or phorbol 12-myristate
13-acetate) remains to be investigated. The fact that SET7/9 is
not required for cell-cycle arrest or p53 stabilization in mice
suggests that the methylation-dependent stimulation of PAR
formation is not required for these aspects but serves for
other, yet to be identified, signalling pathways. Most impor-
tantly, the results presented here may indicate DNA-damage
independent induction of ARTD1 activity in vivo and suggest
that ARTD1 methylation stimulates ADP-ribosylation in
response to other cellular stresses that do not necessarily
involve DNA damage [5].5. Material and methods
5.1. Plasmids and protein expression
pGEX-SET7/9 (52–366) and pcDNA3-SET7/9 (full-length/WT
and H297A) were kindly provided by D. Reinberg (Howard
Hughes Medical Institute, NYU School of Medicine,
New York, NY, USA). pcDNA4-Flag-HA-SET7/9 was created
by subcloning SET7/9 into pcDNA4. pCMV-HA-PARP1 and
pRRL-vectors as described previously [2]. All point mutations
were inserted by site-directedmutagenesis. The construct encod-
ing macroH2A-EGFP was kindly provided by A. Ladurner
(Department of Physiological Chemistry, Ludwig-Maximilians
Universita¨t (LMU) Munich, Munich, Germany).
The baculovirus expression vector BacPak8 (Clontech,
MountainView,CA,USA)wasused for the expressionof recom-
binant proteins in Sf21 insect cells, as described previously [38].
Recombinant GST-tagged proteinswere expressed in Escherichia
coli. All recombinant proteins were purified by a one-step
affinity chromatography using ProBond resin (Invitrogen, Zug,
Switzerland) for His-tagged and glutathione sepharose (GE
Healthcare, Zurich, Switzerland) for GST-tagged proteins,
according to the manufacturer’s recommendations.5.2. Antibodies and siRNAs
The following antibodies were used for immunoblotting:
rabbit PARP-1 (H-250, Santa Cruz, Heidelberg, Germany);
rabbit poly(ADP-ribose) (LP96–10, BD Biosciences, Allschwil,
Switzerland); rabbit SET7/9 (no. 2815, Cell Signalling); mouse
Flag (M2, Sigma-Aldrich, Buchs, Switzerland); mouse tubulin
(T6199, Sigma); rabbit PARP (mono methyl K508) (ab92986)
was generated in collaboration with Abcam (Cambridge, UK)
using a synthetic ARTD1 peptide containing the methylated
lysine residue (LSKKSK(me1)GQVKE).
The following FlexiTube siRNAs (QIAGEN, Hombrechti-
kon, Switzerland) were used in RNAi experiments: AllStars
Negative Control, Hs_SET7_3 and Hs_PARP1_6.
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U2OS cells were cultured in Dulbecco’s modified eagle
medium (PAA Laboratories, Pasching, Austria) supplemented
with 10% FCS and penicillin/streptomycin. MLFs were cul-
tured in the same medium supplemented in addition with
non-essential amino acids (Gibco/Invitrogen). The SET7/9
knockoutMEFs were obtained fromColby Zaph andwere pre-
viously described [26]. Transfections with the indicated
plasmids were performed with TransIT-LT1 (Mirus Bio, Madi-
son, WI, USA) according to the manufacturer’s instructions
and cells were harvested after 48 h. Knockdown was achieved
by reverse transfection of 16 nM siRNA using RNAiMAX
(Invitrogen) according to the manufacturer’s protocol. Cells
were harvested after 3 days. Cells were treated with 1 mM
H2O2 in PBS containing 1 mM MgCl2 for 10 min and with
0.5 mM Adr in normal medium.
Complementation of ARTD1 knockout MLFs was
achieved by retroviral transduction with pRRL-myc-PARP1
vectors containing a blasticidine resistance marker or the
corresponding empty vector. Generation of viruses and
transduction of cells were done as described earlier [39].
5.4. In vitro methylation assays
A 1 mg substrate protein was incubated with 1 mg bacterially
purified GST-SET7/9 in the presence of 0.03 mCi [14C]-SAM
(PerkinElmer) or 0.8 mM cold SAM (Sigma-Aldrich) in
methylation buffer (50 mM Tris–HCl pH8.0, 50 mM NaCl,
10% glycerol, 1 mM PMSF and 1 mM DTT) or PAR buffer
(see section below) for 1 h at 308C. Reactions were stopped
by boiling in 10 SDS-loading buffer and separated by
SDS-PAGE. Gels were stained with Coomassie blue, incuba-
ted in 1 M sodium salicylate for 20 min, dried and exposed
on X-ray films at 2808C. For mass spectrometric analysis,
ARTD1 fragment 373–524 was methylated as described
above, separated by SDS-PAGE, excised from the gel and
digested with Glu-C. Peptides were analysed by MALDI-MS.
5.5. Sequential in vitro modification assays
Sequential ADP-ribosylation and methylation assays were
performed in PAR buffer (50 mM Tris–HCl, 4 mM MgCl2,
250 mM DTT, 1 mg ml21 pepstatin, 1 mg ml21 bestatin and
1 mg ml21 leupeptin). A 10 pmol recombinant ARTD1 was
methylated with 1 mg recombinant GST-SET7/9 as described
above. The ADP-ribosylation was then started by addition
of 5 pmol-activating DNA and 400 mM cold NADþ (Sigma,
after methylation with [14C]-SAM) or 100 mM NADþ spiked
with [32P]-NADþ (Perkin Elmer, after methylation with
cold SAM). ADP-ribosylation reactions were incubated for
5 min at 308C, stopped by addition of 10 SDS-loading
buffer and proteins were separated by SDS-PAGE. Hot
methylation/ADP-ribosylation was assayed by autoradio-
graphy of the Coomassie stained, dried gels, whereas cold
modifications were controlled by immunoblotting with the
indicated antibodies.
In the reverse experiment, 10 pmol ARTD1 was first incu-
bated with activating DNA and 100 mM NADþ for 5 min on
ice. 3-AB (Sigma-Aldrich) was added in a concentration of
8 mM to stop the ADP-ribosylation before the methylation
was started by addition of 1 mg SET7/9 and [14C]-SAM.The activating DNA used in all assays was an annealed
double-stranded oligomer (50-GGAATTCC-30). For sequential
methylation/acetylation, 1 mg ARTD1 fragment (373–524)
was methylated as described above. Acetylation was then
started by addition of 20 ml HAT reaction mix (50 mM
Tris–HCl pH 8.0, 50 mM NaCl, 10% glycerol, 1 mM DTT,
1 mM sodium butyrate, 1 mM PMSF, 0.5 mg p300 and
75 mM [14C]-AcCoA) and allowed to proceed for 1 h at 308C.
5.6. Cellular extracts and ARTD1 activity assays
Whole cell extracts were prepared in lysis buffer (50 mM
Tris–HCl pH7.5, 400 mM NaCl, 1%Triton and 25 mM
NaF), and chromatin fractions were prepared as described
elsewhere [40].
NEs from U2OS cells and complemented MLFs were
generated as described earlier [41,42]. Five microgram NEs
were incubated in 30 ml reaction buffer (50 mM Tris–HCl,
4 mM MgCl2, 1 mg ml
21 pepstatin, 1 mg ml21 bestatin,
1 mg ml21 leupeptin and 250 nM [32P]-NADþ (0.1–0.2 mCi))
in the absence or presence of 5 pmol-activating DNA for
20 min at 308C. Proteins were separated by SDS-PAGE,
and ADP-ribosylation was analysed by autoradiography.
Quantifications were done using the software IMAGEQUANT.
Alternatively, ADP-ribosylation assays were performed
with cold NADþ and modification was assessed by western
blotting with anti-PAR antibody.
5.7. Induction of local DNA damage and imaging
set-up
Local DNA damage was induced by femtosecond laser
irradiation, and recruitment of fluorescently tagged proteins
was recorded as described previously using an LSM 5
Pascal confocal microscope [35,43]. Briefly, cells were
irradiated with femtosecond laser pulses through a 40 oil
immersion lens with a numerical aperture of 1.3 (EC-
Plan-Neo-Fluar, Carl Zeiss) along a 6 mm track within
the nucleus, followed by fluorescence imaging at 488 nm.
The maximum peak irradiance in the focal plane
was 330 GW cm22 (pulse duration 200 fs, repetition rate
40 MHz) for excitation at 775 nm and 1200 GW cm22 (pulse
duration 85 fs, repetition rate 107 MHz) at 1050 nm. Time
series of fluorescence images were quantified with IMAGEJ
(http://rsb.info.nih.gov/ij) as described [43,44].
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